Alignment Healthcare (NASDAQ:ALHC – Get Free Report) will announce its earnings results after the market closes on Thursday, August 1st. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last released its quarterly earnings results on Thursday, May 2nd. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.01). The company had revenue of $628.60 million for the quarter, compared to the consensus estimate of $599.75 million. Alignment Healthcare had a negative return on equity of 91.06% and a negative net margin of 7.81%. The firm’s quarterly revenue was up 43.1% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.20) earnings per share. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Alignment Healthcare Trading Up 2.3 %
Alignment Healthcare stock opened at $8.76 on Wednesday. Alignment Healthcare has a 12-month low of $4.46 and a 12-month high of $10.16. The company has a debt-to-equity ratio of 1.23, a current ratio of 1.57 and a quick ratio of 1.57. The stock has a market capitalization of $1.67 billion, a PE ratio of -10.43 and a beta of 1.43. The firm has a 50 day simple moving average of $8.21 and a 200-day simple moving average of $6.72.
Insider Buying and Selling at Alignment Healthcare
Analyst Upgrades and Downgrades
ALHC has been the subject of a number of research reports. Stephens increased their price target on Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a research note on Friday, May 3rd. Bank of America raised Alignment Healthcare from a “neutral” rating to a “buy” rating and raised their target price for the company from $7.75 to $11.00 in a research note on Thursday, May 30th. Baird R W upgraded shares of Alignment Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Robert W. Baird initiated coverage on shares of Alignment Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $10.00 price objective for the company. Finally, Stifel Nicolaus boosted their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a report on Friday, July 26th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, six have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $9.44.
Read Our Latest Stock Analysis on Alignment Healthcare
Alignment Healthcare Company Profile
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Further Reading
- Five stocks we like better than Alignment Healthcare
- Using the MarketBeat Dividend Yield Calculator
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- Consumer Staples Stocks, Explained
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.